Diagnosis and classification of erythrocytoses and thrombocytoses.
An erythrocytosis describes an increased peripheral blood packed cell volume (PCV) and is deemed to be absolute or apparent depending on whether or not the measured red cell mass (RCM) is above the reference range. This reference range must be related to the individual's height and weight to avoid erroneous interpretations using ml/kg total body weight expressions in obesity. Absolute erythrocytoses are divided into primary, where the erythropoietic compartment is intrinsically abnormal, secondary, where the erythropoietic compartment is normal but is responding to external pathological events leading to an increased erythropoietin drive, and idiopathic, where neither a primary nor a secondary erythrocytosis can be established. Both primary and secondary erythrocytoses have congenital and acquired forms. The only form of primary acquired erythrocytosis that has been defined is the clonal myeloproliferative disorder, polycythaemia vera (PV). Modified diagnostic markers for PV are proposed. Thrombocytoses can be classified into primary, where megakaryopoiesis is intrinsically abnormal, secondary, where megakaryopoiesis is normal but increased platelet production is a reaction to some other unrelated pathology, and finally idiopathic. This latter new group would be used for patients not satisfying the criteria for primary or secondary thrombocytoses, if these were more precise and rigidly used than currently is the case. While theoretically congenital and acquired forms of primary and secondary thrombocytoses might exist, only one cause of secondary congenital thrombocytosis has been established, and primary congenital thrombocytosis has not yet been precisely defined. Primary (essential) thrombocythaemia (PT) is one of the forms of primary acquired thrombocytoses. The diagnostic criteria of PT traditionally involve the exclusion of secondary thrombocytoses and other myeloproliferative disorders but marrow histology could hold a key positive diagnostic role if objective histological features of PT were agreed.
Pearson
T C
TC
Department of Haematological Medicine, Guy's Hospital Medical School, London, UK.
D000886:Anthropometry; D001853:Bone Marrow / Q000473:pathology; D001855:Bone Marrow Diseases / Q000150:complications; D002478:Cells, Cultured; D003952:Diagnostic Imaging; D003955:Diagnostic Tests, Routine; D004911:Erythrocyte Volume; D015672:Erythroid Precursor Cells / Q000187:drug effects; D004921:Erythropoietin / Q000235:genetics; D005260:Female; D006400:Hematocrit; D006453:Hemoglobinopathies / Q000150:complications; D006801:Humans; D000860:Hypoxia / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008297:Male; D009369:Neoplasms / Q000150:complications; D011086:Polycythemia / Q000145:classification / Q000151:congenital / Q000175:diagnosis* / Q000209:etiology; D017467:Receptors, Erythropoietin / Q000235:genetics; D013922:Thrombocytosis / Q000145:classification / Q000151:congenital / Q000175:diagnosis* / Q000209:etiology
D017467:Receptors, Erythropoietin; D004921:Erythropoietin